Back to
Geode Capital Management, LLC
HCWB
4 quarters
Position history for
Geode Capital Management, LLC's holdings in HCW Biologics Inc.
No. Geode Capital Management exited its HCWB (HCW Biologics) position in Q2 2026. Its Q1 2026 13F listed 35,886 shares worth $12,919. Geode Capital Management first reported HCWB in Q3 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$40,709
Total Shares Change
-11,001
Quarter-by-Quarter History
Other major holders of HCWB: HRT Financial LP, Vanguard Group Inc., UBS Group AG, Citadel Advisors LLC, Susquehanna International Group, LLP